The Role of Signaling Pathways in Cervical Cancer and Molecular Therapeutic Targets


Por: Manzo-Merino, J, Contreras-Paredes, A, Vazquez-Ulloa, E, Rocha-Zavaleta, L, Fuentes-Gonzalez, AM, Lizano, M

Publicada: 1 oct 2014
Categoría: Medicine (miscellaneous)

Resumen:
Cervical cancer is a public health issue in developing countries. Although the Pap smear and colposcopy remain the major strategies for detection, most cases are diagnosed in the late stages. Therefore, a major concern has been to develop early diagnostic approaches and more effective treatments. Molecular pathways that participate in cervical malignant transformation have emerged as promising directed therapeutic targets. In this review, we explore some of the major pathways implicated in cervical cancer development, including RAF/MEK/ERK, phosphatidylinositol-3 kinase (PI3K/AKT), Wnt/b-catenin, apoptosis and coupled membrane receptor signaling. We focus on the role of these pathways in cervical carcinogenesis, their alterations and the consequences of these abnormalities. In addition, the most recent preclinical and clinical data on the rationally designed target-based agents that are currently being tested against elements of these pathways are reviewed. (C) 2014 IMSS. Published by Elsevier Inc.

Filiaciones:
Manzo-Merino, J:
 Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed Canc, Mexico City 04510, DF, Mexico

Contreras-Paredes, A:
 Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed Canc, Mexico City 04510, DF, Mexico

Vazquez-Ulloa, E:
 Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed Canc, Mexico City 04510, DF, Mexico

Rocha-Zavaleta, L:
 Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Mol Biol & Biotechnol, Mexico City 04510, DF, Mexico

Fuentes-Gonzalez, AM:
 Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed Canc, Mexico City 04510, DF, Mexico

Lizano, M:
 Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed Canc, Mexico City 04510, DF, Mexico
ISSN: 01884409
Editorial
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, México
Tipo de documento: Review
Volumen: 45 Número: 7
Páginas: 525-539
WOS Id: 000346888600003
ID de PubMed: 25450584

MÉTRICAS